Current Headlines
- Radient Pharmaceuticals Resumes Collaboration To Advance Its Onko-Sure® In Vitro Diagnostic Cancer Test In The USA
- Addex Drug-Candidate Effective In Alzheimer’s Disease Model
- Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro and Aspart With rHuPH20 In Type 1 And Type 2 Diabetes
- QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR
- U.S. Court Of Appeals Upholds Validity Of Lilly's Evista Patents Through March Of 2014
Supplier News
- Document Security Systems, Inc. Signs Licensing Agreement With Pharmaceutical Label Manufacturer
- Maquet SA Adopts Agilent Electronic Lab Notebook Paired With Surety Intellectual Property Integrity Protection
- Small Scale Batch Freeze Drying Services
- Robust Formulations For Viable Probiotic Bacteria
- Lyostat Speeds Process Development At Danisco
Archive Newsletter
- 09.02.2010 -- Orexigen And Takeda Reach Billion Dollar Deal For Obesity Drug
- 08.31.2010 -- Over-Encapsulation: Techniques And Challenges Of Blinding Clinical Trial Material
- 08.26.2010 -- Novartis Pays $28.3 Billion For Majority Ownership Of Alcon
- 08.24.2010 -- HHS Calls For $2B For Improved Emergency Preparedness
- 08.19.2010 -- Studies Pinpoint Key Targets For MRSA Vaccine
Business Wire Press
- Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors For New Vaccine And Biotherapeutics Program
- KYTHERA And Bayer Dermatology Unit Intendis Enter Licensing And Development Agreement For Adipolytic Agent ATX-101
- BARDA Funds Drug Development For Biothreats, Antibiotic Resistance
- Nanotherapeutics Submits Investigational New Drug Application To FDA For Clinical Testing Of Oral Drug To Treat Radiation Exposure
- Genzyme Confirms Receipt of Unsolicited Proposal
GlobeNewswire Press
- Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of SciClone Pharmaceuticals Inc.
- Nabi Biopharmaceuticals Completes Third PentaStaph Milestone
- Penwest Pharmaceuticals Agrees To Be Acquired By Endo Pharmaceuticals For $5.00 Per Share In Cash
- XOMA Receives $750,000 Milestone Payment From AVEO Pharmaceuticals
- NovaBay Pharmaceuticals' Non-Antibiotic Anti-Infective Successful In Phase 2 Skin Infection Trial
Download Library
| | Download software |
Discussion Forums
What's the industry buzz? Join a discussion forum to find out. Connect with your colleagues…ask questions, share information, discuss recent trends.
Join the discussion...
Events Calendar
| | Search events |
| | Post events |
| | Stay informed |
Learn more...
Associations
Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...
Browse now...